We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Zuzana Kovacova

Zuzana Kovacova PhD

Postdoctoral research scientist, Translational Research Institute for Metabolism and Diabetes

Dr. Zuzana Kovacova is a postdoctoral research scientist at the Translational Research Institute for Metabolism and Diabetes. She is focusing on translational human research investigating the effects of natriuretic peptides on metabolism, energy expenditure and insulin sensitivity in humans. Her projects are also to investigate the regulatory mechanisms and novel effects of natriuretic peptides in adipose tissue and muscle. Obesity is associated with dysregulated activity of the natriuretic peptide system which may lead to the development of insulin resistance. This suggests that the natriuretic peptide system could represent a novel therapeutic approach for the treatment of insulin resistance and the metabolic complications associated with obesity.

Dr. Kovacova completed her Master of Sciences at Comenius University in Bratislava, Slovakia with specialization in Genetics and Molecular biology. In 2011, she earned her PhD in Biological Sciences at the Third Faculty of Medicine, Charles University in Prague with the state exam in Cellular and Molecular biology, Genetics and Virology.


Dr. Kovacova reports no disclosures.